热门话题-ARS制药公司股价上涨,因其第一季度营收超出预期

路透中文
May 15
热门话题-ARS制药公司股价上涨,因其第一季度营收超出预期

5月15日 - ** 制药公司ARS Pharmaceuticals(SPRY.O)的股价在盘前交易中上涨2.4%,至8.31美元

** 据LSEG数据显示,该公司 (link) 公布第一季度营收为2270万美元,高于分析师平均预期的2223万美元

** SPRY公布净亏损6062万美元,而市场预期为亏损5187万美元

** 该公司表示,预计明年年初前,大多数州的医疗补助计划将把其鼻喷雾剂Neffy纳入其无限制处方集

** Neffy是ARS旗下获FDA批准的鼻喷雾剂,用于治疗包括过敏性休克在内的严重过敏反应

** 截至上一交易日收盘,SPRY股价年内累计下跌31.8%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10